A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

Clinical trial NCT07038005 · RECRUITING

Trial details

NCT number: NCT07038005
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2025-07-30
Primary completion: 2026-09-22
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.